180 related articles for article (PubMed ID: 16382343)
21. Functional and morphological comparison of three primary liver cell types cultured in the AMC bioartificial liver.
Poyck PP; Hoekstra R; van Wijk AC; Attanasio C; Calise F; Chamuleau RA; van Gulik TM
Liver Transpl; 2007 Apr; 13(4):589-98. PubMed ID: 17394165
[TBL] [Abstract][Full Text] [Related]
22. Treatment of acetaminophen-induced acute liver failure in the mouse with conditionally immortalized human hepatocytes.
Nguyen TH; Mai G; Villiger P; Oberholzer J; Salmon P; Morel P; Bühler L; Trono D
J Hepatol; 2005 Dec; 43(6):1031-7. PubMed ID: 16169114
[TBL] [Abstract][Full Text] [Related]
23. Hepatocyte cell therapy in liver disease.
Bartlett DC; Newsome PN
Expert Rev Gastroenterol Hepatol; 2015; 9(10):1261-72. PubMed ID: 26212798
[TBL] [Abstract][Full Text] [Related]
24. Life support of artificial liver: development of a bioartificial liver to treat liver failure.
Kobayashi N
J Hepatobiliary Pancreat Surg; 2009; 16(2):113-7. PubMed ID: 19110648
[TBL] [Abstract][Full Text] [Related]
25. Comparison of porcine hepatocytes with human hepatoma (C3A) cells for use in a bioartificial liver support system.
Wang L; Sun J; Li L; Mears D; Horvat M; Sheil AG
Cell Transplant; 1998; 7(5):459-68. PubMed ID: 9786066
[TBL] [Abstract][Full Text] [Related]
26. Growth and albumin secretion of mouse fetal liver cells cryopreserved within porous polymer scaffolds as a viable cell source for bioartificial livers.
Miyoshi H; Iwamoto A; Koyama T
J Biosci Bioeng; 2020 Aug; 130(2):212-216. PubMed ID: 32312490
[TBL] [Abstract][Full Text] [Related]
27. Cell choice for bioartificial livers.
Kobayashi N; Okitsu T; Tanaka N
Keio J Med; 2003 Sep; 52(3):151-7. PubMed ID: 14529147
[TBL] [Abstract][Full Text] [Related]
28. Biologic liver support: optimal cell source and mass.
Morsiani E; Brogli M; Galavotti D; Pazzi P; Puviani AC; Azzena GF
Int J Artif Organs; 2002 Oct; 25(10):985-93. PubMed ID: 12456040
[TBL] [Abstract][Full Text] [Related]
29. Immortalization of hepatic progenitor cells.
Weber A
Pathol Biol (Paris); 2004 Mar; 52(2):93-6. PubMed ID: 15001238
[TBL] [Abstract][Full Text] [Related]
30. Bioartificial liver systems: current status and future perspective.
Park JK; Lee DH
J Biosci Bioeng; 2005 Apr; 99(4):311-9. PubMed ID: 16233796
[TBL] [Abstract][Full Text] [Related]
31. Improved survival of porcine acute liver failure by a bioartificial liver device implanted with induced human functional hepatocytes.
Shi XL; Gao Y; Yan Y; Ma H; Sun L; Huang P; Ni X; Zhang L; Zhao X; Ren H; Hu D; Zhou Y; Tian F; Ji Y; Cheng X; Pan G; Ding YT; Hui L
Cell Res; 2016 Feb; 26(2):206-16. PubMed ID: 26768767
[TBL] [Abstract][Full Text] [Related]
32. Peritoneal implantation of cryopreserved encapsulated porcine hepatocytes in rats without immunosuppression: viability and function.
Baldini E; Cursio R; De Sousa G; Margara A; Honiger J; Saint-Paul MC; Bayer P; Raimondi V; Rahmani R; Mouiel J; Gugenheim J
Transplant Proc; 2008; 40(6):2049-52. PubMed ID: 18675127
[TBL] [Abstract][Full Text] [Related]
33. Porcine endogenous retrovirus released by a bioartificial liver infects primary human cells.
Frühauf JH; Mertsching H; Giri S; Frühauf NR; Bader A
Liver Int; 2009 Nov; 29(10):1553-61. PubMed ID: 19686312
[TBL] [Abstract][Full Text] [Related]
34. Development of a protocol for cryopreservation of hepatocytes for use in bioartificial liver systems.
Lloyd TD; Orr S; Berry DP; Dennison AR
Ann Clin Lab Sci; 2004; 34(2):165-74. PubMed ID: 15228229
[TBL] [Abstract][Full Text] [Related]
35. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
[TBL] [Abstract][Full Text] [Related]
36. Characterization of Liver-Specific Functions of Human Fetal Hepatocytes in Culture.
Chinnici CM; Timoneri F; Amico G; Pietrosi G; Vizzini G; Spada M; Pagano D; Gridelli B; Conaldi PG
Cell Transplant; 2015; 24(6):1139-53. PubMed ID: 24667036
[TBL] [Abstract][Full Text] [Related]
37. Treatment of fulminant liver failure by transplantation of microencapsulated primary or immortalized xenogeneic hepatocytes.
Mai G; Nguyen TH; Morel P; Mei J; Andres A; Bosco D; Baertschiger R; Toso C; Berney T; Majno P; Mentha G; Trono D; Buhler LH
Xenotransplantation; 2005 Nov; 12(6):457-64. PubMed ID: 16202069
[TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of an immortalized human hepatic stellate cell line for applications in co-culturing with immortalized human hepatocytes.
Pan X; Wang Y; Yu X; Li J; Zhou N; Du W; Zhang Y; Cao H; Zhu D; Chen Y; Li L
Int J Med Sci; 2015; 12(3):248-55. PubMed ID: 25678842
[TBL] [Abstract][Full Text] [Related]
39. First report of cryopreserved human hepatocytes based bioartificial liver successfully used as a bridge to liver transplantation.
Baccarani U; Donini A; Sanna A; Risaliti A; Cariani A; Nardo B; Cavallari A; Martinelli G; Ridolfi L; Bellini G; Scalamogna M; Bresadola F
Am J Transplant; 2004 Feb; 4(2):286-9. PubMed ID: 14974954
[TBL] [Abstract][Full Text] [Related]
40. Bio-artificial liver from cultured human foetal hepatocytes: feasibility and prospects.
Anand AC; Bhonde RR; Kurup S; Kochhar SP
Trop Gastroenterol; 2000; 21(1):22-7. PubMed ID: 10835957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
